Agape ATP Corp
NASDAQ:ATPC
Agape ATP Corp
NASDAQ:ATPC
Price:
4.17
USD
10.32%
Market Closed
Market Cap:
$4.5m
Relative Value
The Relative Value of one
ATPC
stock under the Base Case scenario is
3.3
USD.
Compared to the current market price of 4.17 USD,
Agape ATP Corp
is
Overvalued by 21%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ATPC
Relative Value
Base Case
3.3
USD
Overvaluation 21%
Multiples Across Competitors
ATPC Competitors Multiples
Agape ATP Corp Competitors
Agape ATP Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
|
Agape ATP Corp
NASDAQ:ATPC
|
4.5m USD | 3.1 | -1.7 | -1.6 | -1.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
114.9B USD | 0.3 | 26.5 | 18.6 | 20.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.1B USD | 0.2 | 42 | 14.7 | 18.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62B CNY | 1.4 | 16.8 | 12.9 | 12.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.3 | 11 | 15.4 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
